Navigation Links
Coenzyme Q10 may reduce risk of Parkinson's disease

The naturally occurring compound coenzyme Q10 is the first treatment to actually slow down Parkinson's disease, rather than just treating its symptoms. The current treatments for Parkinson's disease// can help alleviate the movement disorders that accompany the condition, but they do not actually stop the underlying brain damage. In Parkinson's, cells in the substantia nigra, at the base of the brain, are slowly destroyed, leading to a number of motor and emotional symptoms.

In a preliminary study, the popular food supplement coenzyme Q10 actually seems to slow down the progress of the disease, as opposed to treating the symptoms. Researchers at the University of California gave a group of 80 people with Parkinson's either a varying dose of coenzyme Q10 (300, 600 or 1200 milligrams a day) or placebo for 16 months, assessing various aspects of their illness every four months.

Those on the highest dose of coenzyme Q10 had far better ratings than those on placebo - being 44 per cent better at the end of the study. The researchers believe that the compound actually slows down the condition, but want to carry out brain imaging studies to confirm this.


'"/>




Page: 1

Related medicine news :

1. New Study to look at the Beneficial Effects of Coenzyme Q10 on Parkinson’s disease
2. Stress reduces your immunity- startling but true!!!!!
3. Risk of Cancer can be reduced to 40% with a High Fiber Diet
4. Thirty minutes of work up per day reduces the risk of Diabetes
5. Aspirin reduces deaths
6. Stop smoking and reduce weight
7. Statins reduce heart attacks
8. Vitamins reduce pre-eclampsia
9. Exercises reduce risks of cancers
10. Frequent meals can reduce cholesterol
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Coenzyme may reduce risk Parkinson disease

(Date:8/28/2015)... ... , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based substance abuse ... Mission” benefit concert in Mendon, IL. Held in the Show Barn at the Adams ... education programs in the underfunded local school districts of Mendon at neighboring Quincy, IL. ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this software allows businesses to track product movement from beginning to ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the ... Places to Work in Healthcare by Modern Healthcare and will be honored at ... in its eighth year, the Best Places to Work in Healthcare program recognizes outstanding ...
(Date:8/28/2015)... ... ... Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain and associated ... pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his Bachelor of ... earn his title of Doctor of Chiropractic from the Palmer College of Chiropractic and ...
(Date:8/28/2015)... ... 2015 , ... Northridge dentists Dr. Elyson and Dr. Assili are ... can currently receive a one hour treatment of this teeth whitening option. Zoom ... number of unique features that can turn teeth up to nine shades whiter. Effective ...
Breaking Medicine News(10 mins):Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... , MONDAY, April 9 (HealthDay News) -- People who stay ... because they feel they don,t have a choice are at ... "When employees stay with their organization because they feel ... to experience emotional exhaustion. This feeling, in turn, may lead ...
... Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will ... on their individual genomes and the genomes of their ... sequences: one from the patients, healthy cells before treatment, ... one after. Patients will be paired with mouse "avatars" ...
... News) -- Not only do regular dental exams help keep ... cancer, the Academy of General Dentistry says. As part ... that people get a dental exam from a general dentist ... dentist, ask about an oral cancer screening," academy spokesperson Dr. ...
... more pronounced in individuals with an unacknowledged attraction to ... parents who forbade such desires, a series of psychology ... document the role that both parenting and sexual orientation ... of homosexuals, including self-reported homophobic attitudes, discriminatory bias, implicit ...
... receiving in-patient rehabilitation are more likely to land back ... functioning poorly, show signs of depression and lack social ... Medical Branch (UTMB) at Galveston. Hospital readmission for older ... $18 billion annually. , Among the first of ...
... News) -- Surgery for esophageal cancer can result ... new study finds. Common complaints among patients ... surgery include breathlessness, fatigue, insomnia and eating problems, ... Sweden. Patients who experienced a serious complication after ...
Cached Medicine News:Health News:Mayo Clinic launches whole genome breast cancer study 2Health News:Mayo Clinic launches whole genome breast cancer study 3Health News:Dentists Play Key Role in Detecting Oral Cancer 2Health News:Is some homophobia self-phobia? 2Health News:Is some homophobia self-phobia? 3Health News:Is some homophobia self-phobia? 4Health News:Predictors identified for rehospitalization among post-acute stroke patients 2Health News:Predictors identified for rehospitalization among post-acute stroke patients 3Health News:Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says 2
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" report ... was approved by CFDA to treat wet age- related ... product of Novartis, is available in the Chinese market. ... drug for the treatment of wet AMD in ...
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company ... on the Mylan N.V. ("Mylan") (NASDAQ: MYL ) ... Perrigo. "Our views of Mylan,s offer to ... be, based on our Board,s careful reflection of the ... on the limited choices that Mylan has allowed its ...
(Date:8/28/2015)... HERTFORDSHIRE, England and PITTSBURGH ... (NASDAQ: MYL ) today announced that its ... Company plc (NYSE: PRGO ; TASE) and ... Perrigo,s shareholders at an extraordinary general meeting of ... of two-thirds of the votes cast at the extraordinary general ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... Inc. (Nasdaq: NLTX ), a biopharmaceutical company ... disease, today announced that Michael R. Bristow, M.D. Ph.D. ... of CD-NP, a dual natriuretic peptide receptor agonist in ... Dr. Bristow, a recognized leader in ...
... Oct. 7 Reportlinker.com announces that a new ... U.S. Venous Access Catheter Market ... This study covers U.S. markets for venous access ... venous catheters (CVCs), dialysis catheters, implantable ports, and ...
Cached Medicine Technology:Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 2Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board 3Reportlinker Adds U.S. Venous Access Catheter Market 2Reportlinker Adds U.S. Venous Access Catheter Market 3Reportlinker Adds U.S. Venous Access Catheter Market 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: